Premium
Quanterix Corporation (QTRX)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-31 | Dr. Michael MillerChief Technology & Products Officer | -39,00 | 119,34 | Derivative Exercise and Sale | 3,06 | 33,80k | - |
| 2026-05-31 | Dr. Michael MillerChief Technology & Products Officer | 91,00 | 0,00 | Derivative Exercise and Retained Stock | - | 33,80k | 0,27% |
| 2026-05-15 | Ms. Vandana SriramCFO & Treasurer | -548,00 | 1,51k | Derivative Exercise and Sale | 2,75 | 30,00k | - |
| 2026-05-15 | Ms. Vandana SriramCFO & Treasurer | 1,29k | 0,00 | Derivative Exercise and Retained Stock | - | 30,00k | 4,48% |
| 2026-05-15 | Dr. Michael MillerChief Technology & Products Officer | -467,00 | 1,28k | Derivative Exercise and Sale | 2,75 | 33,70k | - |
| 2026-05-15 | Dr. Michael MillerChief Technology & Products Officer | 1,09k | 0,00 | Derivative Exercise and Retained Stock | - | 33,70k | 3,35% |
| 2026-04-30 | Dr. Michael MillerChief Technology & Products Officer | -39,00 | 122,07 | Derivative Exercise and Sale | 3,13 | 32,61k | - |
| 2026-04-30 | Dr. Michael MillerChief Technology & Products Officer | 91,00 | 0,00 | Derivative Exercise and Retained Stock | - | 32,61k | 0,28% |
| 2026-04-15 | Dr. Michael MillerChief Technology & Products Officer | -467,00 | 1,68k | Derivative Exercise and Sale | 3,60 | 32,52k | - |
| 2026-04-15 | Dr. Michael MillerChief Technology & Products Officer | 1,09k | 0,00 | Derivative Exercise and Retained Stock | - | 32,52k | 3,47% |
| 2026-04-15 | Ms. Vandana SriramCFO & Treasurer | -548,00 | 1,97k | Derivative Exercise and Sale | 3,60 | 28,71k | - |
| 2026-04-15 | Ms. Vandana SriramCFO & Treasurer | 1,29k | 0,00 | Derivative Exercise and Retained Stock | - | 28,71k | 4,68% |
| 2026-03-31 | Dr. Michael MillerChief Technology & Products Officer | -69,00 | 242,88 | Derivative Exercise and Sale | 3,52 | 31,43k | - |
| 2026-03-31 | Dr. Michael MillerChief Technology & Products Officer | 160,00 | 0,00 | Derivative Exercise and Retained Stock | - | 31,43k | 0,51% |
| 2026-03-15 | Dr. Michael MillerChief Technology & Products Officer | 1,01k | 0,00 | Derivative Exercise and Retained Stock | - | 31,27k | 3,33% |
| 2026-03-15 | Dr. Michael MillerChief Technology & Products Officer | -549,00 | 2,59k | Derivative Exercise and Sale | 4,72 | 31,27k | - |
| 2026-03-15 | Ms. Vandana SriramCFO & Treasurer | 1,19k | 0,00 | Derivative Exercise and Retained Stock | - | 27,43k | 4,53% |
| 2026-03-15 | Ms. Vandana SriramCFO & Treasurer | -645,00 | 3,04k | Derivative Exercise and Sale | 4,72 | 27,43k | - |
| 2026-02-15 | Ms. Vandana SriramCFO & Treasurer | 506,00 | 0,00 | Derivative Exercise and Retained Stock | - | 26,24k | 1,97% |
| 2026-02-15 | Ms. Vandana SriramCFO & Treasurer | -271,00 | 1,56k | Derivative Exercise and Sale | 5,74 | 26,24k | - |
| 2026-02-04 | Ms. Vandana SriramCFO & Treasurer | -4,40k | 0,00 | Sale to Issuer | - | 25,73k | -14,59% |
| 2026-01-15 | Dr. Masoud ToloueInitié | -1,82k | 14,45k | Sale to Issuer | 7,95 | 300,91k | -0,60% |
| 2026-01-15 | Ms. Vandana SriramCFO & Treasurer | -274,00 | 2,18k | Sale to Issuer | 7,95 | 17,45k | -1,55% |
| 2025-12-31 | Dr. Masoud ToloueInitié | -258,00 | 1,64k | Sale to Issuer | 6,36 | 297,08k | -0,09% |
| 2025-12-15 | Dr. Masoud ToloueInitié | -1,24k | 9,20k | Sale to Issuer | 7,41 | 296,58k | -0,42% |
| 2025-12-15 | Ms. Vandana SriramCFO & Treasurer | -229,00 | 1,70k | Sale to Issuer | 7,41 | 1,33k | -14,74% |
| 2025-11-30 | Dr. Masoud ToloueInitié | -254,00 | 1,84k | Sale to Issuer | 7,26 | 294,10k | -0,09% |
| 2025-11-15 | Ms. Vandana SriramCFO & Treasurer | -229,00 | 1,32k | Sale to Issuer | 5,78 | 777,00 | -22,76% |
| 2025-11-15 | Dr. Masoud ToloueInitié | -1,24k | 7,13k | Sale to Issuer | 5,74 | 293,59k | -0,42% |
| 2025-10-31 | Dr. Masoud ToloueInitié | -254,00 | 1,36k | Sale to Issuer | 5,34 | 292,36k | -0,09% |
| 2025-10-15 | Dr. Masoud ToloueInitié | -1,24k | 7,18k | Sale to Issuer | 5,78 | 291,85k | -0,42% |
| 2025-10-15 | Ms. Vandana SriramCFO & Treasurer | -229,00 | 1,32k | Sale to Issuer | 5,78 | 15,85k | -1,42% |
| 2025-09-30 | Dr. Masoud ToloueInitié | -254,00 | 1,38k | Sale to Issuer | 5,43 | 289,37k | -0,09% |
| 2025-09-15 | Ms. Vandana SriramCFO & Treasurer | -229,00 | 1,14k | Sale to Issuer | 4,97 | 14,52k | -1,55% |
| 2025-09-15 | Dr. Masoud ToloueInitié | -1,24k | 6,17k | Sale to Issuer | 4,97 | 288,86k | -0,43% |
| 2025-09-12 | Ms. Vandana SriramCFO & Treasurer | 4,15k | 19,88k | Achat | 4,79 | 14,52k | 40,00% |
| 2025-08-31 | Dr. Masoud ToloueInitié | -254,00 | 1,16k | Sale to Issuer | 4,55 | 286,38k | -0,09% |
| 2025-08-15 | Ms. Vandana SriramCFO & Treasurer | -229,00 | 1,05k | Sale to Issuer | 4,57 | 10,60k | -2,11% |
| 2025-08-15 | Dr. Masoud ToloueInitié | -1,24k | 5,68k | Sale to Issuer | 4,57 | 285,88k | -0,43% |
| 2025-07-31 | Dr. Masoud ToloueInitié | -254,00 | 1,51k | Sale to Issuer | 5,94 | 283,40k | -0,09% |
| 2025-07-15 | Dr. Masoud ToloueInitié | -1,24k | 6,82k | Sale to Issuer | 5,49 | 282,89k | -0,44% |
| 2025-07-15 | Ms. Vandana SriramCFO & Treasurer | -229,00 | 1,26k | Sale to Issuer | 5,49 | 10,06k | -2,23% |
| 2025-06-18 | Kent Lake PR LLCSociété | -387,47k | 2,43M | Vente | 6,11 - 6,49 | 2,09M | -15,64% |
| 2025-06-30 | Dr. Masoud ToloueInitié | -254,00 | 1,69k | Sale to Issuer | 6,65 | 280,41k | -0,09% |
| 2025-06-15 | Ms. Vandana SriramCFO & Treasurer | -229,00 | 1,39k | Sale to Issuer | 6,06 | 9,51k | -2,35% |
| 2025-06-15 | Dr. Masoud ToloueInitié | -1,24k | 7,53k | Sale to Issuer | 6,06 | 275,90k | -0,45% |
| 2025-06-12 | Dr. David R. WaltCo-Founder & Chairman of Scientific Advisory Board | 160,00k | 984,97k | Achat | 6,14 - 6,23 | 1,86M | 9,41% |
| 2025-06-09 | Dr. Masoud ToloueInitié | 45,90k | 248,72k | Achat | 5,42 | 273,42k | 20,17% |
| 2025-06-06 | Dr. David R. WaltCo-Founder & Chairman of Scientific Advisory Board | 210,00k | 1,13M | Achat | 5,34 - 5,43 | 1,70M | 14,10% |
| 2025-06-06 | Mr. William P. DonnellyExecutive Chair | 93,11k | 506,35k | Achat | 5,44 | 126,14k | 281,94% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
